Anticancer drugs
| Drugs | Indications |
|---|---|
| Dacomitinib tablets 15mg/30mg/45mg | Metastatic non-small cell lung cancer (NSCLC) |
| Alpelisib film coated tablets 50mg/150mg/200mg | Advanced or metastatic breast cancer |
| Pixantrone 29mg injection | Relapsed or refractory aggresive Non-Hodgkins B- Cell Lymphomas (NHL) |
| Capmatinib 150mg/200mg film coated tablets | Metastatic non-small cell lung cancer (NSCLC) |
| Rucaparib tablets 200mg/250mg/300mg | 1) Ovarian cancer 2) Prostate cancer |
| Darolutamide 300mg film coated tablets | Nonmetastatic castration resistant prostate cancer (nmCRPC) |
| Trifluridine 15mg/20mg + Tipiracil 6.14mg/8.19mg | 1) Metastatic colorectal cancer 2) Metastatic gastric or gastroesophageal junction adenocarcinoma |
| Selumetinib 10mg/25mg capsules | Neurofibromatosis type 1 (NF1) |
| Gimeracil 4.35mg/5.8mg + Oteracil 11.8mg/15.8mg + Tegafur 15mg/20mg capsules | Advanced gastric cancer |
| Pralsetinib 100mg capsules | 1) Metastatic non-small cell lung cancer (NSCLC) 2) Metastatic thyroid cancer |